Norplant as a contraceptive device in Enugu, eastern Nigeria.
This paper is an evaluation of acceptability and use-experience with the contraceptive device Norplant at the University of Nigeria Teaching Hospital, Enugu, Eastern Nigeria. Over a period of 36 months, 173 women (8% of the clinic population) accepted the implant. Use of Norplant was concentrated among high-parity women, and the proportion of Norplant users was highest among women aged 30-34 years. Comparing Norplant and IUD users, we found Norplant users to be significantly less highly educated with < 1% of Norplant users having tertiary education compared to 25% of new IUD users. The continuation rate with Norplant was 89% at three years, suggesting this method has the potential for improving the low contraceptive prevalence in this region.
Ozumba
B
B
Department of Obstetrics and Gynecology, University of Nigeria Teaching Hospital, Enugu, Nigeria.
Chukudebelu
W
W
Snow
R
R
D017677:Age Distribution; D016009:Chi-Square Distribution; D002755:Choice Behavior; D003271:Contraceptive Agents, Female / Q000627:therapeutic use*; D003430:Cross-Sectional Studies; D004522:Educational Status; D005260:Female; D006801:Humans; D007434:Intrauterine Devices; D016912:Levonorgestrel / Q000627:therapeutic use*; D009549:Nigeria; D010298:Parity; D010342:Patient Acceptance of Health Care; D011247:Pregnancy; D012189:Retrospective Studies; D018709:Statistics, Nonparametric
D003271:Contraceptive Agents, Female; D016912:Levonorgestrel